Wang S - Search Results

1

Development and evaluation of a test program for Y-site compatibility testing of total parenteral nutrition and intravenous drugs.

Staven V, Wang S, Grønlie I, Tho I. Staven V, et al. Among authors: wang s. Nutr J. 2016 Mar 22;15:29. doi: 10.1186/s12937-016-0149-x. Nutr J. 2016. PMID: 27000057 Free PMC article.

2

Utilization of the tyndall effect for enhanced visual detection of particles in compatibility testing of intravenous fluids: validity and reliability.

Staven V, Waaseth M, Wang S, Grønlie I, Tho I. Staven V, et al. Among authors: wang s. PDA J Pharm Sci Technol. 2015 Mar-Apr;69(2):270-83. doi: 10.5731/pdajpst.2015.01020. PDA J Pharm Sci Technol. 2015. PMID: 25868993

3

Physical compatibility of total parenteral nutrition and drugs in Y-site administration to children from neonates to adolescents.

Staven V, Iqbal H, Wang S, Grønlie I, Tho I. Staven V, et al. Among authors: wang s. J Pharm Pharmacol. 2017 Apr;69(4):448-462. doi: 10.1111/jphp.12647. Epub 2016 Oct 7. J Pharm Pharmacol. 2017. PMID: 27714809

4

Physical stability of an all-in-one parenteral nutrition admixture for preterm infants upon mixing with micronutrients and drugs.

Staven V, Wang S, Grønlie I, Tho I. Staven V, et al. Among authors: wang s. Eur J Hosp Pharm. 2020 Jan;27(1):36-42. doi: 10.1136/ejhpharm-2018-001562. Epub 2018 Jul 7. Eur J Hosp Pharm. 2020. PMID: 32064087 Free PMC article.

5

Off-label and unlicensed medicines to hospitalised children in Norway.

Teigen A, Wang S, Truong BT, Bjerknes K. Teigen A, et al. Among authors: wang s. J Pharm Pharmacol. 2017 Apr;69(4):432-438. doi: 10.1111/jphp.12581. Epub 2016 Jun 23. J Pharm Pharmacol. 2017. PMID: 27334565 Free PMC article.

6

Manipulating tablets and capsules given to hospitalised children in Norway is common practice.

Bjerknes K, Bøyum S, Kristensen S, Brustugun J, Wang S. Bjerknes K, et al. Among authors: wang s. Acta Paediatr. 2017 Mar;106(3):503-508. doi: 10.1111/apa.13700. Epub 2017 Jan 22. Acta Paediatr. 2017. PMID: 27935163

7

Formulations in paediatric investigation plans (PIPs): Introduction to PIP quality section and regulatory framework.

Wang S. Wang S. Int J Pharm. 2015 Aug 15;492(1-2):332-4. doi: 10.1016/j.ijpharm.2015.05.016. Epub 2015 May 7. Int J Pharm. 2015. PMID: 25959119 No abstract available.

8

Oral medicine acceptance in infants and toddlers: measurement properties of the caregiver-administered Children's acceptance tool (CareCAT).

Blume J, Ruano AL, Wang S, Jackson DJ, Tylleskär T, Strand LI. Blume J, et al. Among authors: wang s. BMC Pediatr. 2018 Mar 22;18(1):117. doi: 10.1186/s12887-018-1080-4. BMC Pediatr. 2018. PMID: 29566668 Free PMC article.

9

Assessment of swallowability and palatability of oral dosage forms in children: Report from an M-CERSI pediatric formulation workshop.

Ternik R, Liu F, Bartlett JA, Khong YM, Thiam Tan DC, Dixit T, Wang S, Galella EA, Gao Z, Klein S. Ternik R, et al. Among authors: wang s. Int J Pharm. 2018 Feb 5;536(2):570-581. doi: 10.1016/j.ijpharm.2017.08.088. Epub 2017 Aug 24. Int J Pharm. 2018. PMID: 28844897

10

Efficacy assessment in paediatric studies.

Wang S, Laitinen-Parkkonen P. Wang S, et al. Handb Exp Pharmacol. 2011;205:149-68. doi: 10.1007/978-3-642-20195-0_7. Handb Exp Pharmacol. 2011. PMID: 21882110

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118,523 results

Search Page

Filters